OBJECTIVES: Our objective was to examine all suicides (n = 423) in 2 geographic areas of the Veterans Health Administration (VHA) over a 7-year period and to perform detailed chart reviews on the subsample that had a VHA visit in the last year of life (n = 381). METHODS: Within this sample, we compared a group with 1 or more documented psychiatric symptoms (68.5%) to a group with no such symptoms (31.5%). The groups were compared on suicidal thoughts and behaviors, somatic symptoms, and stressors using the χ(2) test and on time to death after the last visit using survival analyses. RESULTS: Veterans with documented psychiatric symptoms were more likely to receive a suicide risk assessment, and have suicidal ideation and a suicide plan, sleep problems, pain, and several stressors. These veterans were also more likely to die in the 60 days after their last visit. CONCLUSIONS: Findings indicated presence of 2 large and distinct groups of veterans at risk for suicide in the VHA, underscoring the value of tailored prevention strategies, including approaches suitable for those without identified psychiatric symptoms.
OBJECTIVES: Our objective was to examine all suicides (n = 423) in 2 geographic areas of the Veterans Health Administration (VHA) over a 7-year period and to perform detailed chart reviews on the subsample that had a VHA visit in the last year of life (n = 381). METHODS: Within this sample, we compared a group with 1 or more documented psychiatric symptoms (68.5%) to a group with no such symptoms (31.5%). The groups were compared on suicidal thoughts and behaviors, somatic symptoms, and stressors using the χ(2) test and on time to death after the last visit using survival analyses. RESULTS: Veterans with documented psychiatric symptoms were more likely to receive a suicide risk assessment, and have suicidal ideation and a suicide plan, sleep problems, pain, and several stressors. These veterans were also more likely to die in the 60 days after their last visit. CONCLUSIONS: Findings indicated presence of 2 large and distinct groups of veterans at risk for suicide in the VHA, underscoring the value of tailored prevention strategies, including approaches suitable for those without identified psychiatric symptoms.
Authors: Mark A Ilgen; Kara Zivin; Karen L Austin; Amy S B Bohnert; Ewa K Czyz; Marcia Valenstein; Amy M Kilbourne Journal: Suicide Life Threat Behav Date: 2010-12
Authors: Mark A Ilgen; Amy S B Bohnert; Rosalinda V Ignacio; John F McCarthy; Marcia M Valenstein; H Myra Kim; Frederic C Blow Journal: Arch Gen Psychiatry Date: 2010-11
Authors: Gregory K Brown; Thomas Ten Have; Gregg R Henriques; Sharon X Xie; Judd E Hollander; Aaron T Beck Journal: JAMA Date: 2005-08-03 Impact factor: 56.272
Authors: Marcia Valenstein; Hyungjin Myra Kim; Dara Ganoczy; John F McCarthy; Kara Zivin; Karen L Austin; Katherine Hoggatt; Daniel Eisenberg; John D Piette; Frederic C Blow; Mark Olfson Journal: J Affect Disord Date: 2008-10-22 Impact factor: 4.839
Authors: John F McCarthy; Marcia Valenstein; H Myra Kim; Mark Ilgen; Kara Zivin; Frederic C Blow Journal: Am J Epidemiol Date: 2009-02-27 Impact factor: 4.897
Authors: Wilfred R Pigeon; Peter C Britton; Mark A Ilgen; Ben Chapman; Kenneth R Conner Journal: Am J Public Health Date: 2012-01-25 Impact factor: 9.308
Authors: Peter C Britton; Kipling M Bohnert; Mark A Ilgen; Cathleen Kane; Brady Stephens; Wilfred R Pigeon Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-04-11 Impact factor: 4.328
Authors: Kate H Bentley; Joseph C Franklin; Jessica D Ribeiro; Evan M Kleiman; Kathryn R Fox; Matthew K Nock Journal: Clin Psychol Rev Date: 2015-12-02
Authors: Erin P Finley; Mary Bollinger; Polly H Noël; Megan E Amuan; Laurel A Copeland; Jacqueline A Pugh; Albana Dassori; Raymond Palmer; Craig Bryan; Mary Jo V Pugh Journal: Am J Public Health Date: 2015-02 Impact factor: 9.308
Authors: Robert J Ursano; Ronald C Kessler; James A Naifeh; Holly B Herberman Mash; Matthew K Nock; Pablo A Aliaga; Carol S Fullerton; Gary H Wynn; Tsz Hin H Ng; Hieu M Dinh; Nancy A Sampson; Tzu-Cheg Kao; Steven G Heeringa; Murray B Stein Journal: JAMA Psychiatry Date: 2018-10-01 Impact factor: 21.596